ARK Foundation | TB & Tobacco Project
portfolio_page-template-default,single,single-portfolio_page,postid-348947,eltd-cpt-1.0,ajax_updown_fade,page_not_loaded,,arkfoundation-ver-1.5, vertical_menu_with_scroll,smooth_scroll,blog_installed,wpb-js-composer js-comp-ver-4.12.1,vc_responsive

TB & Tobacco Project

Project Description

The project is on Tobacco cessation within TB programmes: A ‘real world‘ solution for countries with dual burden of disease. The overall objective of the TB & Tobacco project is to reduce the burden of lung diseases in low- and middle-income countries by smoking cessation. It is a two arm double blinded randomized control trial study.


The effectiveness of Cytisine in achieving abstinence and improving outcomes in TB patients: A two-arm, double blind, randomised, placebo-controlled trial’ in collaboration with University of York, UK and University of Leeds, UK. This 36 months study is funded by European Commission (EC). The aim of the study is to assess the effectiveness of Cytisine when added to behavioural support in helping tuberculosis patients who use tobacco in quitting tobacco use successfully and in improving their clinical outcomes.


Project Details

1. Tobacco Control